In vitro activities of six fluoroquinolones against Canadian isolates of vancomycin-sensitive and vancomycin-resistant Enterococcus species

Diagn Microbiol Infect Dis. 1998 Jun;31(2):343-7. doi: 10.1016/s0732-8893(98)00019-4.

Abstract

The in vitro activities of six fluoroquinolones were determined against 1482 Enterococcus species isolates collected as part of a 1996 Canadian surveillance study. Clinafloxacin MIC90s were 4 or 8 microg/mL, trovafloxacin and BAY 12-8039 MIC90s were 8 or 16 microg/mL, sparfloxacin MIC90s were 32 microg/mL, and ciprofloxacin and ofloxacin MIC90s were >32 microg/mL for the vancomycin-sensitive Enterococcus faecalis, vancomycin-sensitive Enterococcus faecium, and vancomycin-resistant E. faecium isolates collected.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Anti-Infective Agents / pharmacology*
  • Aza Compounds*
  • Canada
  • Ciprofloxacin / pharmacology
  • Drug Resistance, Microbial
  • Enterococcus / drug effects*
  • Enterococcus / isolation & purification
  • Fluoroquinolones*
  • Humans
  • Microbial Sensitivity Tests
  • Moxifloxacin
  • Naphthyridines / pharmacology
  • Ofloxacin / pharmacology
  • Quinolines*
  • Quinolones / pharmacology
  • Vancomycin / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Aza Compounds
  • Fluoroquinolones
  • Naphthyridines
  • Quinolines
  • Quinolones
  • Ciprofloxacin
  • Vancomycin
  • clinafloxacin
  • trovafloxacin
  • Ofloxacin
  • sparfloxacin
  • Moxifloxacin